CIBC Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$787K Buy
7,180
+342
+5% +$48.7K ﹤0.01% 728
2025
Q4
$1.14M Buy
6,838
+1,988
+41% +$333K ﹤0.01% 694
2025
Q3
$950K Hold
4,850
﹤0.01% 685
2025
Q2
$439K Hold
4,850
﹤0.01% 786
2025
Q1
$289K Buy
4,850
+93
+2% +$8.6K ﹤0.01% 885
2024
Q4
$630K Buy
4,757
+237
+5% +$22.2K ﹤0.01% 718
2024
Q3
$237K Buy
+4,520
New +$212K ﹤0.01% 993

Other funds holding ALAB

CIBC Asset Management's ALAB Position: Q1 2026 in Review

CIBC Asset Management increased its Astera Labs (ALAB) stake by 5% in Q1 2026, buying an estimated $48.7K and bringing the position to 7,180 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

CIBC Asset Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.14M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • CIBC Asset Management held 7,180 shares of Astera Labs worth $787K as of Q1 2026.
  • CIBC Asset Management bought 342 Astera Labs shares in Q1 2026, an estimated $48.7K.
  • Astera Labs made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #728 holding.
  • CIBC Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • CIBC Asset Management's Astera Labs position peaked at $1.14M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.